You may qualify for one of our clinical trials! For more information about joining a clinical trial, please email research@
You Deserve the Best in Advanced Orthopedic Care
Clinical Trials for Orthopedic Pain
CURRENTLY RECRUITING
VIVEX - A Phase III Clinical Trial Using Donor Nucleus Pulposus Tissue for Degenerative Disc Disease
This is a Phase 3 clinical trial of the investigational therapy VIA Disc NP for the treatment of Lumbar Degenerative Disc Disease. VIA Disc NP uses donor cadaveric nucleus pulposus tissue processed and injected into affected spinal discs to reduce chronic low back pain and improve function. This single, minimally invasive injection may offer a regenerative approach for patients who have not found relief through conservative treatments. The study involves a minimum of 6 visits over 24 months with visit compensation.
Learn more about Disc Degeneration >>
Learn more about this study >>
Learn more about this trial >>
CURRENTLY RECRUITING
Pacira - A Phase III Clinical Trial Using Cryotherapy for Upper Limb Spasticity
This is a Phase 3 clinical trial of the investigational device iovera° for treating upper limb spasticity in patients with confirmed cerebral or spinal conditions. The ultrasound-guided iovera° system uses cryoneurolysis to temporarily freeze targeted nerves, reducing spasticity and pain signals. Possible benefits include long-term relief and improved quality of life. This study involves a minimum of 5 visits to our site over 13 weeks, with all treatments provided at no cost and compensation for follow-up visits.
Learn more about this study >>
Learn more about this trial >>
CURRENTLY RECRUITING
Mesoblast - Phase III Clinical Trial for Degenerative Disc Disease and Low Back Pain
This is a Phase 3 clinical trial of the investigational drug REXLEMESTROCEL-L combined with Hyaluronic Acid for the treatment of Lumbar Degenerative Disc Disease. REXLEMESTROCEL-L (Mesenchymal Precursor Cells) + 1% Hyaluronic Acid are administered by an injection into the spinal disc. Possible benefits include the reduction of pain-related disability associated with degenerative disc disease. This study involves a minimum of 7 visits to our site over the course of 24 months and includes a stipend for each follow-up visit.
Learn more about Disc Degeneration >>
Learn more about this study >>
Learn more about this trial >>
CURRENTLY RECRUITING
BioRestorative - Phase II Clinical Trial for Degenerative Disc Disease and Low Back Pain
This is a Phase 2 clinical trial of the investigational drug BRTX-100 (autologous hypoxic-cultured Mesenchymal Precursor Cells from bone marrow + autologous platelet lysate (APL) ) for the treatment of Lumbar Degenerative Disc Disease. BRTX-100 administered by an injection into the spinal disc. Possible benefits include the reduction of pain-related disability associated with degenerative disc disease. This study involves a minimum of 7 visits to our site over the course of 24 months and includes a stipend for each visit.
Learn more about Disc Degeneration >>
Learn more about this study >>
Learn more about this trial >>
